-
19
2021-01Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, announced it is in advanced discussions with the European Commission (EC) for -
15
2021-01The COVID-19 vaccine from pharmaceutical companies Pfizer and BioNTech looks to be effective against 16 different mutations of the coronavirus, according to a study that has not yet undergone peer rev -
13
2021-01The African Union has secured close to 300 million COVID-19 vaccine doses in the largest such agreement yet for Africa, a continental official said Tuesday. -
09
2021-01Serious allergic reactions after COVID-19 vaccines are likely more common than serious reactions following flu vaccines, but are still very rare, according to a new report. -
08
2021-01A vaccine candidate made by China's Sinovac is 78% effective in protecting against COVID-19, according to results of a study announced Thursday by Brazilian state health officials seeking federal -
24
2020-12Europe’s medicines regulator on Monday authorized Pfizer and BioNTech’s coronavirus vaccine for conditional use, opening the door to an inoculation program across the European Union. -
21
2020-12The Food and Drug Administration has approved Moderna’s coronavirus vaccine for emergency use. The vaccine — the second approved for use in the U.S. behind Pfizer and BioNTech’s — bolsters the U.S··· -
15
2020-12Vaccinations against the coronavirus began in the US on Monday morning, with some of the first doses of the Pfizer vaccine being given to health care workers in New York. The vaccinations began on the -
11
2020-12Canada on Wednesday approved the Pfizer-BioNTech COVID-19 vaccine, days after Britain became the first country to greenlight and roll it out. -
10
2020-12India's health ministry announced Tuesday that some COVID-19 vaccines are likely to receive licenses in the next few weeks and outlined an initial plan to immunize 300 million people. -
09
2020-12The U.K. rolled out the first coronavirus vaccines to the public on Tuesday, making it the first country to inoculate people with a treatment that went through full testing. -
27
2020-11The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published in mBio, an open-access journal of the American Society for Microbiology, re -
23
2020-11Pfizer Inc. and BioNTech SE announced they will submit a request today to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of their mRNA vaccine candidate, BNT162b2 ag -
19
2020-11Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates to ensure that the most effectiv -
19
2020-11GSK recently announced that its Respiratory Syncytial Virus (RSV) candidate vaccines for maternal immunisation (GSK3888550A) and older adults (GSK3844766A) were well-tolerated and highly immunogenic i